Eflucimibe

CAS No. 202340-45-2

Eflucimibe( —— )

Catalog No. M34231 CAS No. 202340-45-2

Eflucimibe (L0081) is an acyl coenzyme A: cholesterol acyltransferase inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, and can be used to study atherosclerosis and hyperlipidemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 409 Get Quote
10MG 604 Get Quote
25MG 908 Get Quote
50MG 1251 Get Quote
100MG 1647 Get Quote
500MG 3312 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Eflucimibe
  • Note
    Research use only, not for human use.
  • Brief Description
    Eflucimibe (L0081) is an acyl coenzyme A: cholesterol acyltransferase inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, and can be used to study atherosclerosis and hyperlipidemia.
  • Description
    Eflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor. Eflucimibe can be used in the research of atherosclerosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Acyltransferase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    202340-45-2
  • Formula Weight
    469.72
  • Molecular Formula
    C29H43NO2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H](C(NC1=C(C)C(C)=C(O)C(C)=C1)=O)(SCCCCCCCCCCCC)C2=CC=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nathalie Mesplet, et al. Analysis of eflucimibe and related impurities by highly sensitive liquid chromatography-electrospray-tandem mass spectrometry. The Journal of Separation Science. 2003.
molnova catalog
related products
  • Gymnemagenin

    Gymnemagenin is a potent and selective antagonist for the β isoform of LXR it has antihyperglycemic activity.

  • MOG (35-55)

    MOG (35-55) is a truncated peptide derived from the human Myelin Oligodendrocyte Glycoprotein (MOG).?

  • Pomalidomide-C2-NH2

    Pomalidomide-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a linker.